Profile data is unavailable for this security.
About the company
Cumberland Pharmaceuticals Inc. is a specialty pharmaceutical company. The Company is focused on the acquisition, development and commercialization of branded prescription pharmaceutical products. Its portfolio of brands includes Acetadote injection, for the treatment of acetaminophen poisoning; Caldolor injection, for the treatment of pain and fever, Kristalose for oral solution, a prescription laxative, for the treatment of constipation, and Omeclamox-Pak, oral, for the treatment of Helicobacter pylori infection and related duodenal ulcer disease. Its brands also include Sancuso transdermal, for the prevention of nausea and vomiting in patients receiving certain types of chemotherapy treatment; Vaprisol injection, to raise serum sodium levels in hospitalized patients with euvolemic and hypervolemic hyponatremia, and Vibativ injection for the treatment of certain serious bacterial infections, including hospital-acquired and ventilator-associated bacterial pneumonia.
- Revenue in USD (TTM)36.79m
- Net income in USD-10.87m
- Incorporated1999
- Employees91.00
- LocationCumberland Pharmaceuticals Inc2525 W End Ave Ste 950NASHVILLE 37203-1608United StatesUSA
- Phone+1 (615) 255-0068
- Fax+1 (615) 255-0094
- Websitehttps://www.cumberlandpharma.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Aytu Biopharma Inc | 75.48m | -6.63m | 9.27m | 99.00 | -- | 0.3109 | 11.07 | 0.1229 | -1.26 | -1.22 | 11.72 | 4.85 | 0.6069 | 1.92 | 2.85 | 762,393.90 | -5.33 | -27.76 | -10.87 | -46.03 | 68.61 | 58.88 | -8.79 | -56.45 | 0.80 | -- | 0.357 | -- | -24.58 | 61.73 | 7.08 | -- | -- | -- |
| Onconetix Inc | 1.46m | -53.12m | 9.37m | 12.00 | -- | -- | -- | 6.40 | -104.90 | -104.90 | 2.89 | 50.92 | 0.0328 | 3.45 | 5.30 | 121,979.20 | -119.09 | -- | -215.11 | -- | -57.21 | -- | -3,629.24 | -- | 0.091 | -11.87 | 0.2984 | -- | -- | -- | -176.78 | -- | -- | -- |
| NDT Pharmaceuticals Inc | -100.00bn | -100.00bn | 9.51m | 1.00 | -- | 0.0531 | -- | -- | -- | -- | -- | 1.12 | -- | -- | -- | -- | -- | -164.47 | -- | -452.47 | -- | -- | -- | -6,891.36 | -- | -- | 0.00 | -- | -100.00 | -- | 87.56 | -- | -- | -- |
| Integrated BioPharma, Inc. | 51.02m | 430.00k | 9.79m | 147.00 | 24.91 | 0.5014 | 12.68 | 0.1919 | 0.0131 | 0.0131 | 1.63 | 0.6488 | 1.93 | 4.29 | 11.92 | 347,068.00 | 1.63 | 13.15 | 2.12 | 19.97 | 8.67 | 11.22 | 0.8428 | 5.87 | 1.18 | -- | 0.00 | -- | -0.7006 | 0.1357 | 806.25 | -41.77 | 5.96 | -- |
| Bio Essence Corp | 593.21k | -1.02m | 9.88m | 12.00 | -- | -- | -- | 16.66 | -0.0278 | -0.0156 | 0.0158 | -0.0458 | 0.3305 | -- | 21.20 | -- | -57.09 | -46.10 | -- | -- | 25.05 | 33.89 | -172.74 | -111.21 | -- | -59.99 | 7.03 | -- | -11.27 | -10.94 | -52.03 | -- | -48.19 | -- |
| Immunoprecise Antibodies Ltd | 17.25m | -19.76m | 10.05m | 102.00 | -- | 0.4045 | -- | 0.5825 | -0.7468 | -0.7468 | 0.6593 | 0.8614 | 0.3546 | 6.12 | 6.16 | -- | -40.63 | -26.70 | -46.68 | -30.31 | 48.21 | 56.13 | -114.58 | -85.72 | 0.8189 | -134.72 | 0.3289 | -- | 18.65 | 17.54 | -2.32 | -- | 16.71 | -- |
| Talphera Inc | 281.00k | -15.64m | 11.88m | 15.00 | -- | 1.23 | -- | 42.28 | -0.6786 | -0.6792 | 0.0118 | 0.5662 | 0.0127 | -- | -- | 18,733.33 | -70.64 | -22.60 | -82.44 | -28.55 | -- | -- | -5,565.48 | -714.87 | -- | -- | 0.00 | -- | -- | -21.26 | -119.16 | -- | -34.33 | -- |
| Gelteq Ltd | 0.00 | -1.54m | 14.82m | -- | -- | 1.05 | -- | -- | -0.1611 | -0.1611 | 0.00 | 1.50 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 1.38 | -32.41 | 0.0605 | -- | -- | -- | -72.77 | -- | -- | -- |
| Cumberland Pharmaceuticals, Inc. | 36.79m | -10.87m | 15.17m | 91.00 | -- | 0.6107 | -- | 0.4123 | -0.7692 | -0.7692 | 2.61 | 1.77 | 0.4472 | 0.9316 | 3.07 | 404,235.70 | -13.18 | -7.03 | -20.32 | -9.52 | 83.31 | 79.95 | -29.48 | -17.64 | 0.9884 | -29.44 | 0.3967 | -- | -5.85 | 6.15 | -12.73 | -- | -36.17 | -- |
| Bright Green Corp | 0.00 | -9.03m | 15.33m | 5.00 | -- | 1.71 | -- | -- | -0.0485 | -0.0485 | 0.00 | 0.0467 | 0.00 | -- | -- | 0.00 | -44.63 | -- | -73.32 | -- | -- | -- | -- | -- | -- | -13,031.30 | 0.0828 | -- | -- | -- | 52.54 | -- | -- | -- |
| TherapeuticsMD Inc | 1.60m | -3.97m | 15.34m | 1.00 | -- | 0.5661 | -- | 9.61 | -0.3499 | -0.291 | 0.1399 | 2.35 | 0.0355 | -- | 0.4944 | 1,596,000.00 | -8.81 | -53.35 | -11.41 | -111.61 | 31.45 | 86.67 | -248.56 | -236.57 | -- | -- | 0.00 | -- | -98.14 | -39.53 | -816.85 | -- | -- | -- |
| Cara Therapeutics Inc | 8.69m | -95.53m | 17.01m | 55.00 | -- | 24.05 | -- | 1.96 | -1.75 | -1.75 | 0.1589 | 0.0129 | 0.1042 | 0.6312 | 4.59 | 157,927.30 | -114.63 | -35.76 | -142.84 | -40.82 | 56.44 | -- | -1,099.76 | -162.10 | 4.71 | -- | 0.00 | -- | -49.92 | 9.26 | -38.65 | -- | 100.66 | -- |
| Marinus Pharmaceuticals Inc | 31.47m | -140.49m | 17.75m | 165.00 | -- | -- | -- | 0.5642 | -2.47 | -2.47 | 0.5524 | -1.21 | 0.238 | 0.6542 | 7.75 | 190,703.00 | -106.26 | -49.64 | -140.93 | -57.76 | 90.17 | -- | -446.49 | -518.96 | 1.47 | -10.06 | -- | -- | 21.63 | -- | -613.59 | -- | 7.47 | -- |
| DH Enchantment Inc | 100.00 | -173.19k | 19.54m | 1.00 | -- | -- | -- | 195,396.80 | -0.0002 | -0.0002 | 0.00 | -0.0012 | 0.0438 | 0.1493 | -- | 100.00 | -7,579.43 | -- | -- | -- | 0.00 | -- | -173,190.00 | -- | 0.0029 | -14.85 | -- | -- | -95.43 | -- | 59.53 | -- | -- | -- |
| Cyclo Therapeutics Inc | 870.72k | -24.80m | 20.06m | 8.00 | -- | -- | -- | 23.04 | -0.9232 | -0.9232 | 0.0322 | -0.4683 | 0.1605 | 0.342 | 3.54 | 108,840.00 | -457.10 | -132.22 | -- | -215.17 | 91.24 | 90.37 | -2,848.18 | -1,114.04 | 0.1614 | -- | -- | -- | -21.76 | 1.25 | -29.81 | -- | -3.95 | -- |
Data as of Nov 22 2024. Currency figures normalised to Cumberland Pharmaceuticals Inc's reporting currency: US Dollar USD
13.71%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Renaissance Technologies LLCas of 30 Sep 2024 | 528.16k | 3.75% |
| The Vanguard Group, Inc.as of 30 Sep 2024 | 374.25k | 2.66% |
| Bridgeway Capital Management LLCas of 30 Sep 2024 | 286.66k | 2.03% |
| Dimensional Fund Advisors LPas of 30 Sep 2024 | 265.23k | 1.88% |
| Acadian Asset Management LLCas of 30 Sep 2024 | 188.16k | 1.34% |
| BlackRock Fund Advisorsas of 30 Sep 2024 | 81.97k | 0.58% |
| Geode Capital Management LLCas of 30 Sep 2024 | 74.31k | 0.53% |
| Newton Investment Management North America LLCas of 30 Sep 2024 | 71.84k | 0.51% |
| SSgA Funds Management, Inc.as of 30 Sep 2024 | 33.70k | 0.24% |
| BlackRock Financial Management, Inc.as of 30 Sep 2024 | 28.10k | 0.20% |
More ▼
Data from 30 Sep 2024 - 30 Sep 2024Source: FactSet Research Systems Inc.
